Product correctly added to cart.

discount label
CP 424174
View 3D

Biosynth logo

CP 424174

CAS: 210825-31-3

Ref. 3D-KIA82531

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Monday 1 Jul 2024

Product Information

Name:
CP 424174
Description:

CP 424174 is a drug that inhibits the activity of vascular endothelial growth factor (VEGF) and is used as a treatment for eye disorders. CP 424174 is administered locally to the eye in the form of an ophthalmic solution. It acts by binding to proteins on the surface of cells, which are responsible for cell adhesion, proliferation, and migration. The drug prevents these proteins from performing their function and can be used to treat disease when there has been damage to retinal tissue or other tissues in the eye. CP 424174 is injected into the sclera (the white part of the eye) using a small needle that is inserted through a small incision made near the edge of the cornea. The drug reaches its target tissue by diffusing through scleral vessels, which are very thin and permeable. This drug has been shown to be effective against neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The effective dose depends on body weight and

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
452.99 g/mol
Formula:
C22H29ClN2O4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-KIA82531 CP 424174

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".